Detail Information of Exogenous Modulation
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0055 Transporter Info | ||||
Gene Name | ABCB9 | ||||
Transporter Name | TAP-like protein | ||||
Gene ID | |||||
UniProt ID | |||||
Exogenous factors (drugs, dietary constituents, etc.) Modulation of This DT (EGM) | |||||
---|---|---|---|---|---|
Chemical Compound |
|||||
DT Modulation1 |
Cisplatin affects the expression of ABCB9 mRNA | [4] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
Cisplatin co-treated with jinfukang results in increased expression of ABCB9 mRNA | [5] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation1 |
Toluene results in increased methylation of ABCB9 gene | [12] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation1 |
Benzo(a)pyrene affects the methylation of ABCB9 5' UTR | [20] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
Benzo(a)pyrene affects the methylation of ABCB9 intron | [21] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation3 |
Benzo(a)pyrene results in increased methylation of ABCB9 3' UTR | [20] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
1-Methyl-3-isobutylxanthine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F results in increased expression of ABCB9 mRNA | [15] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
2,2',4,4'-tetrabromodiphenyl ether |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
2,2',4,4'-tetrabromodiphenyl ether analog results in decreased expression of ABCB9 mRNA | [16] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
aristolochic acid I |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
aristolochic acid I results in increased expression of ABCB9 mRNA | [18] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
beta-lapachone |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
beta-lapachone results in increased expression of ABCB9 mRNA | [22] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
bisphenol F |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F results in increased expression of ABCB9 mRNA | [15] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Cadmium Chloride |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Cadmium Chloride results in increased expression of ABCB9 mRNA | [4] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
CGP 52608 |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
CGP 52608 promotes the reaction RORA protein binds to ABCB9 gene | [23] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
chloroacetaldehyde |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
chloroacetaldehyde results in increased expression of ABCB9 mRNA | [4] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Dexamethasone |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F results in increased expression of ABCB9 mRNA | [15] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Diazinon |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Diazinon results in increased methylation of ABCB9 gene | [24] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Indomethacin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F results in increased expression of ABCB9 mRNA | [15] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Okadaic Acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Okadaic Acid results in increased expression of ABCB9 mRNA | [25] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Oxygen |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Oxygen deficiency results in increased expression of ABCB9 mRNA | [4] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
pentabromodiphenyl ether |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
pentabromodiphenyl ether analog results in decreased expression of ABCB9 mRNA | [16] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
S-(1,2-dichlorovinyl)cysteine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides which results in increased expression of ABCB9 mRNA | [26] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Silicon Dioxide |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Silicon Dioxide results in decreased expression of ABCB9 mRNA | [27] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Valproic Acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Valproic Acid results in increased methylation of ABCB9 gene | [28] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Approved Drug |
|||||
Raloxifene Hydrochloride |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Raloxifene Hydrochloride affects the expression of ABCB9 | [1] | |||
Progesterone |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Progesterone inhibits the expression of ABCB9 | [2] | |||
Zidovudine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Zidovudine increases the expression of ABCB9 | [3] | |||
Cidofovir |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Cidofovir increases the expression of ABCB9 | [4] | |||
Ifosfamide |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Ifosfamide increases the expression of ABCB9 | [4] | |||
Cisplatin |
3 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Cisplatin increases the expression of ABCB9 | [5] | |||
Urethane |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Urethane increases the expression of ABCB9 | [6] | |||
Doxorubicin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Doxorubicin inhibits the expression of ABCB9 | [7] | |||
Drug Marketed but not Approved by US FDA |
|||||
Clodronic Acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Clodronic Acid increases the expression of ABCB9 | [4] | |||
Drug in Phase 3 Trial |
|||||
Resveratrol |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Resveratrol increases the expression of ABCB9 | [10] | |||
Natural Product |
|||||
Tobacco Smoke Pollution |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Tobacco Smoke Pollution increases the expression of ABCB9 | [14] | |||
Environmental toxicant |
|||||
Zinc |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Zinc increases the expression of ABCB9 | [9] | |||
Mycotoxins |
|||||
Aflatoxin B1 |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Aflatoxin B1 increases the expression of ABCB9 | [8] | |||
DT Modulation2 |
Aflatoxin B1 results in increased methylation of ABCB9 gene | [17] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Carcinogen |
|||||
Benzo(a)pyrene |
4 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Benzo(a)pyrene increases the expression of ABCB9 | [13] | |||
Arsenic |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Arsenic affects the methylation of ABCB9 gene | [19] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Health and Environmental Toxicant |
|||||
tris(1,3-dichloro-2-propyl)phosphate |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
tris(1,3-dichloro-2-propyl)phosphate inhibits the expression of ABCB9 | [11] | |||
Toluene |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Toluene inhibits the expression of ABCB9 | [12] | |||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.